🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/01/2001 | 77,10 | 79,20 | 76,15 | 78,42 | +1,46% | 3,96% | 6.249.958 |
| 30/01/2001 | 77,19 | 77,77 | 76,35 | 77,29 | +0,86% | 1,84% | 3.846.579 |
| 29/01/2001 | 78,53 | 79,63 | 76,15 | 76,63 | -2,36% | 4,44% | 4.289.988 |
| 26/01/2001 | 78,96 | 80,15 | 78,18 | 78,48 | +0,46% | 2,49% | 5.546.330 |
| 25/01/2001 | 75,92 | 78,24 | 75,80 | 78,13 | +3,72% | 3,22% | 7.649.562 |
| 24/01/2001 | 76,10 | 76,34 | 75,02 | 75,32 | -0,79% | 1,72% | 8.815.776 |
| 23/01/2001 | 77,17 | 77,17 | 74,96 | 75,92 | -3,34% | 2,86% | 11.981.679 |
| 22/01/2001 | 79,79 | 79,79 | 78,36 | 78,54 | -0,15% | 1,79% | 4.609.418 |
| 19/01/2001 | 78,36 | 79,85 | 78,36 | 78,66 | -0,53% | 1,90% | 5.638.659 |
| 18/01/2001 | 77,77 | 80,15 | 77,65 | 79,08 | +2,00% | 3,22% | 5.440.378 |
| 17/01/2001 | 79,20 | 79,50 | 77,29 | 77,53 | -2,48% | 2,79% | 6.769.032 |
| 16/01/2001 | 77,65 | 80,57 | 76,81 | 79,50 | +2,30% | 4,84% | 5.764.943 |
| 12/01/2001 | 78,13 | 79,50 | 77,29 | 77,71 | -0,23% | 2,82% | 5.280.453 |
| 11/01/2001 | 79,68 | 79,79 | 77,17 | 77,89 | -1,88% | 3,29% | 6.979.575 |
| 10/01/2001 | 80,21 | 80,93 | 78,30 | 79,38 | -0,97% | 3,27% | 6.469.199 |
| 09/01/2001 | 80,09 | 81,11 | 79,26 | 80,15 | +0,60% | 2,31% | 6.389.761 |
| 08/01/2001 | 80,15 | 80,63 | 78,90 | 79,68 | +0,23% | 2,16% | 5.143.165 |
| 05/01/2001 | 81,11 | 81,88 | 79,32 | 79,50 | -1,99% | 3,16% | 9.799.324 |
| 04/01/2001 | 84,39 | 84,51 | 79,91 | 81,11 | -4,63% | 5,44% | 19.205.543 |
| 03/01/2001 | 88,56 | 88,74 | 84,09 | 85,04 | -4,17% | 5,25% | 10.308.128 |
| 02/01/2001 | 89,10 | 90,89 | 88,26 | 88,74 | -0,67% | 2,95% | 6.332.959 |
| 29/12/2000 | 90,65 | 91,54 | 89,16 | 89,34 | -1,19% | 2,63% | 3.916.481 |
| 28/12/2000 | 89,34 | 90,41 | 89,16 | 90,41 | +2,23% | 1,40% | 3.281.917 |
| 27/12/2000 | 88,50 | 90,35 | 88,38 | 88,44 | +0,00% | 2,22% | 5.269.658 |
| 26/12/2000 | 86,71 | 88,98 | 86,30 | 88,44 | +2,42% | 3,09% | 3.810.842 |
| 22/12/2000 | 88,62 | 88,62 | 86,12 | 86,36 | -2,16% | 2,83% | 5.113.611 |
| 21/12/2000 | 88,74 | 89,34 | 86,83 | 88,26 | -0,94% | 2,82% | 7.699.970 |
| 20/12/2000 | 88,74 | 90,77 | 88,20 | 89,10 | +2,05% | 2,89% | 10.115.191 |
| 19/12/2000 | 84,09 | 88,08 | 84,09 | 87,31 | +2,45% | 4,75% | 5.295.230 |
| 18/12/2000 | 85,88 | 86,30 | 84,74 | 85,22 | -1,18% | 1,81% | 5.236.122 |